Classification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration

被引：0
|
作者：
Bommakanti, Nikhil
Young, Benjamin K.
Sisk, Robert A.
Berrocal, Audina M.
Duncan, Jacque L.
Bakall, Benjamin
Mathias, Marc T.
Ahmed, Ishrat
Chorfi, Sarah
Comander, Jason
Nagiel, Aaron
Besirli, Cagri G.
机构：
来源：
OPHTHALMOLOGY | 2024年 / 131卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：130 / 130
页数：1
相关论文
共 47 条
  • [11] Cost Effectiveness of Voretigene Neparvovec for RPE65-Mediated Inherited Retinal Degeneration in Germany
    Uhrmann, Matthias Fritz
    Lorenz, Birgit
    Gissel, Christian
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2020, 9 (09): : 1 - 8
  • [12] Prospect of retinal gene therapy following commercialization of voretigene neparvovec-rzyl for retinal dystrophy mediated by RPE65 mutation
    Ameri, Hossein
    JOURNAL OF CURRENT OPHTHALMOLOGY, 2018, 30 (01): : 1 - 2
  • [13] Voretigene neparvovec-rzyl for the treatment of biallelic RPE65 mutation-associated retinal dystrophy
    Russell, Stephen
    Bennett, Jean
    Maguire, Albert M.
    High, Katherine A.
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (08): : 457 - 464
  • [14] Full-field Scotopic Threshold Improvement after Voretigene Neparvovec-rzyl Treatment Correlates with Chorioretinal Atrophy
    Stingl, Katarina
    Stingl, Krunoslav
    Schwartz, Hillary
    Reid, Mark W.
    Kempf, Melanie
    Dimopoulos, Spyridon
    Kortuem, Friederike
    Borchert, Mark S.
    Lee, Thomas C.
    Nagiel, Aaron
    OPHTHALMOLOGY, 2023, 130 (07) : 764 - 770
  • [15] Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease
    Zimmermann, Marita
    Lubinga, Solomon J.
    Banken, Reiner
    Rind, David
    Cramer, Geri
    Synnott, Patricia G.
    Chapman, Richard H.
    Khan, Sonya
    Carlson, Josh
    VALUE IN HEALTH, 2019, 22 (02) : 161 - 167
  • [16] The first gene therapy for RPE65 biallelic dystrophy with voretigene neparvovec-rzyl in Brazil
    Ferraz Sallum, Juliana M.
    Godoy, Juliana
    Kondo, Andrea
    Kutner, Jose Mauro
    Vasconcelos, Huber
    Maia, Andre
    OPHTHALMIC GENETICS, 2022, 43 (04) : 550 - 554
  • [17] Retinal Pigment Epithelium Atrophy After Subretinal Voretigene Neparvovec-rzyl for RPE65-Related Disease: A 6-Month Follow-Up
    Giansanti, Fabrizio
    Mucciolo, Dario Pasquale
    Sodi, Andrea
    Giorgio, Dario
    Virgili, Gianni
    Murro, Vittoria
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2022, 42 (12): : E55 - E56
  • [18] An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK
    Viriato, Daniel
    Bennett, Natalie
    Sidhu, Raisa
    Hancock, Elizabeth
    Lomax, Hannah
    Trueman, David
    MacLaren, Robert E.
    ADVANCES IN THERAPY, 2020, 37 (03) : 1233 - 1247
  • [19] An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK
    Daniel Viriato
    Natalie Bennett
    Raisa Sidhu
    Elizabeth Hancock
    Hannah Lomax
    David Trueman
    Robert E. MacLaren
    Advances in Therapy, 2020, 37 : 1233 - 1247
  • [20] Subretinal Injection of Voretigene Neparvovec-rzyl in a Patient With RPE65-Associated Leber's Congenital Amaurosis
    Hussain, Rehan M.
    Tran, Kimberly D.
    Maguire, Albert M.
    Berrocal, Audina M.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2019, 50 (10): : 661 - 663
12345